BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29514150)

  • 1. High Serum Thyrotropin Concentrations within the Reference Range: A Predictor of Malignancy in Nodular Thyroid Disease.
    Duccini K; de Souza MVL; Delfim R; Aguiar AP; Teixeira P; Vaisman M
    Med Princ Pract; 2018; 27(3):272-277. PubMed ID: 29514150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.
    Boelaert K; Horacek J; Holder RL; Watkinson JC; Sheppard MC; Franklyn JA
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4295-301. PubMed ID: 16868053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum thyrotropin concentration in children with isolated thyroid nodules.
    Mussa A; Salerno MC; Bona G; Wasniewska M; Segni M; Cassio A; Vigone MC; Gastaldi R; Iughetti L; Santanera A; Capalbo D; Matarazzo P; De Luca F; Weber G; Corrias A
    J Pediatr; 2013 Nov; 163(5):1465-70. PubMed ID: 23972643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative TSH level and risk of thyroid cancer in patients with nodular thyroid disease: nodule size contribution.
    Zafón C; Obiols G; Mesa J
    Endocrinol Nutr; 2015 Jan; 62(1):24-8. PubMed ID: 25066642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological correlation of serum TSH in patients with thyroid nodule.
    Mondal HP; Sen S; Sasmal S; Ghosal PK; Mukhopadhyay SK; Mukhopadhyay M
    J Indian Med Assoc; 2011 May; 109(5):330, 335, 338. PubMed ID: 22187768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher TSH can be used as an additional risk factor in prediction of malignancy in euthyroid thyroid nodules evaluated by cytology based on Bethesda system.
    Baser H; Topaloglu O; Tam AA; Evranos B; Alkan A; Sungu N; Dumlu EG; Ersoy R; Cakir B
    Endocrine; 2016 Aug; 53(2):520-9. PubMed ID: 26972701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine-Needle Aspiration Biopsy as a Preoperative Procedure in Patients with Malignancy in Solitary and Multiple Thyroid Nodules.
    Kaliszewski K; Diakowska D; Wojtczak B; Strutyńska-Karpińska M; Domosławski P; Sutkowski K; Głód M; Balcerzak W; Forkasiewicz Z; Łukieńczuk T
    PLoS One; 2016; 11(1):e0146883. PubMed ID: 26784518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum TSH levels as a predictor of malignancy in thyroid nodules: A prospective study.
    Golbert L; de Cristo AP; Faccin CS; Farenzena M; Folgierini H; Graudenz MS; Maia AL
    PLoS One; 2017; 12(11):e0188123. PubMed ID: 29145466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSH levels are associated with increased risk of thyroid carcinoma in patients with nodular disease.
    Fighera TM; Perez CL; Faris N; Scarabotto PC; da Silva TT; Cavalcanti TC; Mesa Junior CO; Miasaki F; da Paz Filho GJ; de Carvalho GA
    Endokrynol Pol; 2015; 66(6):480-5. PubMed ID: 26662646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rational use of fine needle aspiration biopsy (FNAB) in diagnosing thyroid nodules.
    Sidoti M; Marino G; Resmini E; Augeri C; Cappi C; Cavallero D; Lagasio C; Ceppa P; Minuto F; Giusti M
    Minerva Endocrinol; 2006 Jun; 31(2):159-72. PubMed ID: 16682939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion.
    Kim HJ; Mok JO; Kim CH; Kim YJ; Kim SJ; Park HK; Byun DW; Suh K; Yoo MH
    Endocr Res; 2017 May; 42(2):154-162. PubMed ID: 27936964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules.
    Polyzos SA; Kita M; Efstathiadou Z; Poulakos P; Slavakis A; Sofianou D; Flaris N; Leontsini M; Kourtis A; Avramidis A
    J Cancer Res Clin Oncol; 2008 Sep; 134(9):953-60. PubMed ID: 18327610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refined use of scintigraphy in the evaluation of nodular thyroid disease.
    McHenry CR; Slusarczyk SJ; Askari AT; Lange RL; Smith CM; Nekl K; Murphy TA
    Surgery; 1998 Oct; 124(4):656-61; discussion 661-2. PubMed ID: 9780985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease.
    Rago T; Fiore E; Scutari M; Santini F; Di Coscio G; Romani R; Piaggi P; Ugolini C; Basolo F; Miccoli P; Pinchera A; Vitti P
    Eur J Endocrinol; 2010 Apr; 162(4):763-70. PubMed ID: 20083557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of serum thyrotropin for risk prediction of differentiated thyroid cancers does not apply to microcarcinomas: results of 1,870 Chinese patients with thyroid nodules.
    Shi L; Li Y; Guan H; Li C; Shi L; Shan Z; Teng W
    Endocr J; 2012; 59(11):973-80. PubMed ID: 22785429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage.
    Haymart MR; Repplinger DJ; Leverson GE; Elson DF; Sippel RS; Jaume JC; Chen H
    J Clin Endocrinol Metab; 2008 Mar; 93(3):809-14. PubMed ID: 18160464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum thyrotropin as a risk factor for thyroid malignancy in euthyroid subjects with thyroid micronodule.
    Moon SS; Lee YS; Lee IK; Kim JG
    Head Neck; 2012 Jul; 34(7):949-52. PubMed ID: 22127951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of preoperative serum thyroid-stimulating hormone level for predicting malignant nodular thyroid disease.
    Jin J; Machekano R; McHenry CR
    Am J Surg; 2010 Mar; 199(3):294-7; discussion 298. PubMed ID: 20226898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSH Level and Risk of Malignancy in Patients with Bethesda Category IV Thyroid Nodules.
    Fernández-Trujillo C; Pérez-Zaballos J; Rodríguez-Pérez CA; López-Plasencia Y; Marrero-Arencibia D; Cabrera-Galván JJ; Boronat M
    Horm Cancer; 2020 Aug; 11(3-4):200-204. PubMed ID: 32266672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Thyroid Antibodies and TSH as Potential Markers of Thyroid Carcinoma and Aggressive Behavior in Patients with Indeterminate Fine-Needle Aspiration Cytology.
    Adhami M; Michail P; Rao A; Bhatt CR; Grodski S; Serpell JW; Lee JC
    World J Surg; 2020 Feb; 44(2):363-370. PubMed ID: 31502005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.